HomeHPX • FRA
add
Hisamitsu Pharmaceutical Co Inc
Previous close
€25.60
Day range
€25.80 - €25.80
Year range
€21.00 - €28.80
Market cap
364.25B JPY
Avg Volume
6.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Market news
.INX
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
(JPY) | Aug 2024info | Y/Y change |
---|---|---|
Revenue | 39.65B | 13.66% |
Operating expense | 18.75B | 17.95% |
Net income | 4.31B | -1.33% |
Net profit margin | 10.87 | -13.18% |
Earnings per share | — | — |
EBITDA | 6.35B | 20.49% |
Effective tax rate | 28.38% | — |
Balance Sheet
Total assets
Total liabilities
(JPY) | Aug 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 122.74B | -13.22% |
Total assets | 350.48B | 1.79% |
Total liabilities | 74.55B | 7.74% |
Total equity | 275.92B | — |
Shares outstanding | 73.34M | — |
Price to book | 0.01 | — |
Return on assets | 3.52% | — |
Return on capital | 4.46% | — |
Cash Flow
Net change in cash
(JPY) | Aug 2024info | Y/Y change |
---|---|---|
Net income | 4.31B | -1.33% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Saga and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903.
Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
Founded
1847
Headquarters
Website
Employees
2,759